Seeking Alpha

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I...

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I data of its REGN727 for cholesterol management was "impressive." The firm expects its presentation of additional data this weekend to boost the stock further, and reiterates its Buy rating on the shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector